COMPANY OVERVIEW

Ribon Therapeutics is a biotech company focused on developing first-in-class therapeutics targeting mono(ADP-ribosyl)ating PARPs for cancer.

---

LOCATION

Lexington, MA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://ribontx.com

---

CAREER WEBSITE

https://www.ribontx.com/careers/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Mar 9, 2023

Ribon Therapeutics Doses First Patient in Phase 1 Clinical Study with RBN-3143 in Patients with Moderate-to-Severe Atopic Dermatitis

Jan 30, 2023

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Nov 29, 2022

Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim

Sep 6, 2022

Ribon Therapeutics Announces Late-Breaking Presentation of Preclinical Data on RBN-3143 at the European Respiratory Society International Congress 2022

Apr 11, 2022

Ribon Therapeutics Announces Presentations at the American Association for Cancer Research 2022 Annual Meeting

For More Press Releases

---